About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The aim of this group is to develop translational and clinical research in rehabilitation. From the lab-based cellular level of understanding injury to rehabilitation and recovery, our researchers are dedicated to the development and translation of more effective strategies to promote prevention, functional recovery, and improved quality of life after disability.
Our vision: make disability preventable, liveable and curable.
Our mission: conduct research and training towards the development and translation of more effective strategies to promote prevention, functional recovery, and improved quality of life after disability.
Principal investigators, investigators and associate members come together from many different departments at the Rehabilitation Service and reflecting the wide breadth of expertise through the disability. The principal investigators and researchers include professors in Universitat Autònoma and Universitat Blanquerna.
Special objectives in innovation areas with in collaboration with pharmaceutical companies (pluripotencial cells, botulinum toxins), other biotechnology companies (diagnosis, prevention and management), participating in technology transference projects with other research groups, and involvement in projects and networks endorsed by European Scientific Societies.
The Research Group of Physical Medicine and Rehabilitation collaborates with the University of Andorra (UdA), specifically with Mercè Avellanet's team; and with the Universitat Jaume I of Valencia (UJI), team of Carlos Suso.
PMID: 32694749 Journal: SPINAL CORD Year: 2020 Reference: Spinal Cord. 2020 Aug;58(8):841-843. doi: 10.1038/s41393-020-0524-5. Epub 2020 Jul 21. Impact factor: 1.773 Publication type: Editorail in international publication Authors: Sanchez-Raya, Judith, Sampol, Julia et al. DOI: 10.1038/s41393-020-0524-5
PMID: 32638334 Journal: Spine deformity Year: 2020 Reference: Spine Deform. 2020 Dec;8(6):1239-1246. doi: 10.1007/s43390-020-00167-5. Epub 2020 Jul 7. Impact factor: 0 Publication type: Paper in international publication Authors: Sanchez-Raya, Judith, Matamalas, Antonia, Figueras, Clara, Bago, Joan et al. DOI: 10.1007/s43390-020-00167-5
PMID: 32581306 Journal: SPINAL CORD Year: 2020 Reference: Spinal Cord. 2020 Dec;58(12):1249-1254. doi: 10.1038/s41393-020-0506-7. Epub 2020 Jun 24. Impact factor: 1.773 Publication type: Paper in international publication Authors: Sampol, Julia, Gonzalez-Viejo, Miguel Angel, Gomez, Alba, Marti, Sergi, Pallero, Mercedes, Rodriguez, Esther, Launois, Patricia, Sampol, Gabriel, Ferrer, Jaume et al. DOI: 10.1038/s41393-020-0506-7
PMID: 31806386 Journal: MEDICINA CLINICA Year: 2020 Reference: Med Clin (Barc). 2020 Jun 26;154(12):481-487. doi: 10.1016/j.medcli.2019.07.021. Epub 2019 Dec 2. Impact factor: 1.635 Publication type: Paper in national publication Authors: Crespo-Fresno, Almudena, Sanchez-Raya, Judith, Vidal-Guitart, Xavier, Jou-Miralpeix, Nuria, Pages-Bolibar, Esther, Cuxart-Fina, Ampar et al. DOI: 10.1016/j.medcli.2019.07.021
MouthX, developed by the company Aurax, allows people with reduced mobility in the upper extremities to have access to essential digital tools for communication, work and leisure, with the aim of improving their independence and emotional well-being.
The creation of hybrid digital-human interaction spaces between avatars and people offers new opportunities for personalized medicine
En la mateixa trobada la SEP va decidir atorgar per primera vegada una beca per fer formació a l'estranger de dos mesos. La beca es va atorgar a la Dra. Teresa Crespo, adjunta a la Unitat de Lesionats Medul·lars de Vall d’Hebron.
